0001437749-16-031876.txt : 20160513 0001437749-16-031876.hdr.sgml : 20160513 20160513171706 ACCESSION NUMBER: 0001437749-16-031876 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160509 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pioneer Pharma (Singapore) Pte. Ltd. CENTRAL INDEX KEY: 0001558885 STATE OF INCORPORATION: U0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 161649543 BUSINESS ADDRESS: STREET 1: 33A CHANDER ROAD CITY: SINGAPORE STATE: U0 ZIP: 219539 BUSINESS PHONE: 65-98116356 MAIL ADDRESS: STREET 1: 33A CHANDER ROAD CITY: SINGAPORE STATE: U0 ZIP: 219539 4 1 rdgdoc.xml PIONEER X0306 4 2016-05-09 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001558885 Pioneer Pharma (Singapore) Pte. Ltd. 33A CHANDER ROAD SINGAPORE 219539 1 Common Stock 2016-05-09 4 A 0 1308901 1.91 A 2389318 D Warrant 1.91 2016-05-09 4 A 0 654451 0 A 2016-05-09 2020-05-05 Common Stock 654451 835751 D Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 4,079,058 shares to nine accredited investors. The company expects to sell another 2,094,241 pursuant to those same agreements on July 31, 2016. /s/ Justin Hall as attorney in fact for Pioneer Pharma (Singapore) Co Ltd 2016-05-13